These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 32637157)
1. The use of botulinum toxin in keloid scar management: a literature review. Sohrabi C; Goutos I Scars Burn Heal; 2020; 6():2059513120926628. PubMed ID: 32637157 [TBL] [Abstract][Full Text] [Related]
2. The evidence behind the use of platelet-rich plasma (PRP) in scar management: a literature review. Alser OH; Goutos I Scars Burn Heal; 2018; 4():2059513118808773. PubMed ID: 30479843 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of Efficacy of Corticosteroid and Corticosteroid Combined with Botulinum Toxin Type A in the Treatment of Keloid and Hypertrophic Scars: A Meta-Analysis. Liu XG; Zhang D Aesthetic Plast Surg; 2021 Dec; 45(6):3037-3044. PubMed ID: 34184094 [TBL] [Abstract][Full Text] [Related]
4. Intralesional excision as a surgical strategy to manage keloid scars: what's the evidence? Goutos I Scars Burn Heal; 2019; 5():2059513119867297. PubMed ID: 31565400 [TBL] [Abstract][Full Text] [Related]
5. Percutaneous collagen induction (microneedling) for the management of non-atrophic scars: literature review. Iosifidis C; Goutos I Scars Burn Heal; 2019; 5():2059513119880301. PubMed ID: 31807320 [TBL] [Abstract][Full Text] [Related]
6. Steroid tape: A promising adjunct to scar management. Goutos I; Ogawa R Scars Burn Heal; 2017; 3():2059513117690937. PubMed ID: 29799565 [TBL] [Abstract][Full Text] [Related]
7. Treatment of Keloid Scars with Botulinum Toxin Type A versus Triamcinolone in an Athymic Nude Mouse Model. Fanous A; Bezdjian A; Caglar D; Mlynarek A; Fanous N; Lenhart SF; Daniel SJ Plast Reconstr Surg; 2019 Mar; 143(3):760-767. PubMed ID: 30601323 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of botulinum toxin type A for treating post burn hypertrophic scars and keloid in children: An intra-patient randomized controlled study. Tawfik AA; Ali RA J Cosmet Dermatol; 2023 Apr; 22(4):1256-1260. PubMed ID: 36718819 [TBL] [Abstract][Full Text] [Related]
9. The Cellular Response of Keloids and Hypertrophic Scars to Botulinum Toxin A: A Comprehensive Literature Review. Austin E; Koo E; Jagdeo J Dermatol Surg; 2018 Feb; 44(2):149-157. PubMed ID: 29401161 [TBL] [Abstract][Full Text] [Related]
10. The Efficacy of Drug Injection in the Treatment of Pathological Scar: A Network Meta-analysis. Sun P; Lu X; Zhang H; Hu Z Aesthetic Plast Surg; 2021 Apr; 45(2):791-805. PubMed ID: 31853608 [TBL] [Abstract][Full Text] [Related]
11. Recurrence rates in the treatment of keloids and hypertrophic scars with intralesional triamcinolone combined with other intralesional agents. Rimmer SN; Chandy RJ; Khan D; Feldman SR Arch Dermatol Res; 2023 Dec; 315(10):2757-2767. PubMed ID: 37432467 [TBL] [Abstract][Full Text] [Related]
12. The Efficacy and Safety of Botulinum Toxin Injections in Preventing Postoperative Scars and Improving Scar Quality: A Systematic Review and Meta-Analysis. Qiao Z; Yang H; Jin L; Li S; Wang X Aesthetic Plast Surg; 2021 Oct; 45(5):2350-2362. PubMed ID: 33674930 [TBL] [Abstract][Full Text] [Related]
13. Silicone gel sheeting for treating keloid scars. Tian F; Jiang Q; Chen J; Liu Z Cochrane Database Syst Rev; 2023 Jan; 1(1):CD013878. PubMed ID: 36594476 [TBL] [Abstract][Full Text] [Related]
14. The safety and efficacy of intralesional triamcinolone acetonide for keloids and hypertrophic scars: A systematic review and meta-analysis. Zhuang Z; Li Y; Wei X Burns; 2021 Aug; 47(5):987-998. PubMed ID: 33814214 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of surgical excision and sub-dermal injection of triamcinolone acetonide for treatment of keloid scars after caesarean section: a single blind randomised controlled trial protocol. Chua SC; Gidaszewski B; Khajehei M Trials; 2019 Jun; 20(1):363. PubMed ID: 31215471 [TBL] [Abstract][Full Text] [Related]
16. Laser therapy for treating hypertrophic and keloid scars. Leszczynski R; da Silva CA; Pinto ACPN; Kuczynski U; da Silva EM Cochrane Database Syst Rev; 2022 Sep; 9(9):CD011642. PubMed ID: 36161591 [TBL] [Abstract][Full Text] [Related]
17. Intralesional triamcinolone alone or in combination with botulinium toxin A is ineffective for the treatment of formed keloid scar: A double blind controlled pilot study. Rasaii S; Sohrabian N; Gianfaldoni S; Hadibarhaghtalab M; Pazyar N; Bakhshaeekia A; Lotti T; Ramirez-Pacheco LA; Lange CS; Matta J; Seifi V; Ramirez-Fort MK; Feily A Dermatol Ther; 2019 Mar; 32(2):e12781. PubMed ID: 30422367 [TBL] [Abstract][Full Text] [Related]
18. Assessment of intralesional injection of botulinum toxin type A in hypertrophic scars and keloids: Clinical and pathological study. Khatery BHM; Hussein HA; Abd-El-Raheem TA; El Hanbuli HM; Yassen NN Dermatol Ther; 2022 Oct; 35(10):e15748. PubMed ID: 36190006 [TBL] [Abstract][Full Text] [Related]
19. Assessment of laser-assisted delivery vs intralesional injection of botulinum toxin A in treatment of hypertrophic scars and keloids. Sabry HH; Ibrahim EA; Hamed AM Dermatol Ther; 2020 Nov; 33(6):e13980. PubMed ID: 32638463 [TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type A for the treatment and prevention of hypertrophic scars and keloids: Updated review. Kasyanju Carrero LM; Ma WW; Liu HF; Yin XF; Zhou BR J Cosmet Dermatol; 2019 Feb; 18(1):10-15. PubMed ID: 30548742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]